Soothiex Business Plan - Case Study
Soothiex
How Avvale turned Soothiex’s paediatric medicine-compliance concept into a structured 39-page business plan with category positioning, launch strategy, and a clear route to market.

About Soothiex
Soothiex approached Avvale with an early-stage concept for a helper product designed to make children’s liquid medicines easier to take. The business was not being built as a pharmaceutical product or supplement. Instead, it was being positioned as a medicine-adjacent consumer product that could sit naturally beside children’s medicines in homes, pharmacies, and clinical settings.
The core proposition centred on a practical problem faced by parents and caregivers: repeated medicine refusal caused by unpleasant taste, unfamiliar flavours, and the stress that can come with dosing. The opportunity lay in translating that everyday problem into a commercially credible product category with clearer positioning, stronger usability, and a more scalable go-to-market model.
A Recurring Problem in a Large, Familiar Market
Soothiex sits at the intersection of children’s healthcare and consumer packaged goods. The business plan framed the opportunity around a very specific and recurring behavioural pain point: many children resist liquid medicines because of taste, smell, texture, or anxiety, which can lead to missed doses, prolonged illness, and significant stress for caregivers.
What made the concept compelling was that the pain point already exists inside established purchasing behaviour. Parents routinely buy liquid medicines for colds, flu, fever, allergies, and infections through pharmacies and supermarkets. Soothiex was designed to sit alongside that routine, making compliance easier without requiring a change in prescribing habits or trying to become the medicine itself.
From Product Idea to Clear Commercial Case
The business needed more than a generic startup plan. It needed category clarity, a defensible market narrative, and a launch strategy that would make sense to investors, partners, and future retail channels.
- Define Soothiex as a medicine-adjacent companion product rather than a medicine, supplement, or informal workaround
- Validate the commercial opportunity through paediatric OTC demand, UK market sizing, and an initial England beachhead
- Build a phased route to market covering formulation, validation, D2C launch, pharmacy expansion, and partnership growth
- Translate the concept into an investor-ready plan with channel logic, risk management, and a clear funding requirement
How We Built the Plan for Soothiex
Avvale developed a 39-page business plan anchored in the actual user problem rather than broad wellness language. We structured the opportunity around taste-related medicine refusal, parent stress, and the lack of a dedicated consumer category for medicine-compliance support. This helped position Soothiex as a purpose-built, child-friendly helper product that complements medicines without altering their role.
We then shaped the business case across market sizing, positioning, rollout strategy, channel design, and funding logic. The plan mapped a realistic progression from formulation and compliance work to an initial D2C launch, followed by pharmacy distribution, subscriptions and bundles, B2B or institutional sales, and longer-term white-label or co-branded partnerships.
A Full Commercial Blueprint for Launch and Scale
The final deliverable covered executive summary, industry overview, strategy and implementation, competitor analysis, marketing strategy, and financial projections. It included Soothiex’s three-year objectives, key success factors, market need, product features, implementation phases, risk management, SWOT analysis, revenue channels, channel strategy, and ask of funds.
Just as importantly, the plan clarified the brand’s commercial identity. Instead of being framed as a broad children’s health idea, Soothiex was positioned as a trusted companion product within paediatric healthcare: supportive rather than medicinal, child-centred, parent-trusted, and healthcare-adjacent.
A Sharper Business Story with a Clearer Route to Market
The finished plan gave Soothiex a more credible commercial narrative and a more actionable launch roadmap. Instead of presenting the concept too broadly, the business now had a defined category position, a structured initial market entry point, a multi-channel revenue model, and a staged path from validation to wider distribution and partnership growth.
The plan also translated the opportunity into concrete business terms, including a funding requirement of £137,500 to support launch and scale. That gave the client a clearer framework for communicating the opportunity externally and making early strategic decisions internally.
A Stronger Foundation for Launch
39 pages of positioning, market logic, channel strategy, and funding-readiness built around Soothiex’s actual product concept and commercial pathway.
Positioning the Business in the Right Place
In consumer healthcare, good concepts often lose momentum when they are positioned too broadly or too medically. A major part of this work was helping Soothiex sit in the right space: close enough to medicines to feel relevant, but distinct enough to build a consumer-friendly brand, retail presence, and scalable route to market.
That is what turned the deliverable into more than a standard business plan. It became a clearer business case for how Soothiex could create a new, practical category around medicine compliance support and grow from an initial UK beachhead into broader consumer, pharmacy, and partnership channels over time.
Need a business plan for a consumer or healthcare-adjacent brand?
We help founders turn complex product ideas into credible, commercially structured plans that are built for launch, fundraising, and growth.
Muhammad Tayyab Shabbir
Founder & Principal Consultant, Avvale
Muhammad has helped 500+ founders across 40+ countries secure funding and launch their businesses. He specialises in investor-ready business plans, financial models, and pitch decks for startups, SMEs, and visa applicants.
Leave a comment